APO CL 75 (Clopidogrel bisulfate 75 mg (base))

Pill imprint APO CL 75 has been identified as Clopidogrel bisulfate 75 mg (base).

Clopidogrel is used in the treatment of ischemic stroke; peripheral arterial disease; transient ischemic attack; heart attack; ischemic stroke, prophylaxis (and more), and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Clopidogrel 75 mg (base) is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for APO CL 75

Clopidogrel bisulfate 75 mg (base) APO CL 75 Front
Clopidogrel bisulfate 75 mg (base) APO CL 75 Back
Clopidogrel bisulfate
Imprint:
APO
CL 75
Strength:
75 mg (base)
Color:
Red
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Platelet aggregation inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Apotex Corp.
National Drug Code (NDC):
60505-0253
Inactive Ingredients:
lactose anhydrous
silicon dioxide
crospovidone
methylcellulose (15 mPa.s)
zinc stearate
ferric oxide red
hydroxypropyl cellulose
hypromelloses
polyethylene glycol 8000
titanium dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)